D.Y. Wang

1.1k total citations
42 papers, 916 citations indexed

About

D.Y. Wang is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, D.Y. Wang has authored 42 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 15 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Oncology. Recurrent topics in D.Y. Wang's work include Estrogen and related hormone effects (22 papers), Cancer Risks and Factors (10 papers) and Hormonal and reproductive studies (10 papers). D.Y. Wang is often cited by papers focused on Estrogen and related hormone effects (22 papers), Cancer Risks and Factors (10 papers) and Hormonal and reproductive studies (10 papers). D.Y. Wang collaborates with scholars based in United Kingdom, Netherlands and Japan. D.Y. Wang's co-authors include R.D. Bulbrook, J.L. Hayward, John W. Moore, Vera Fantl, R.D. Rubens, R.D. Bulbrook, Ian S. Fentiman, David Tong, H. G. Kwa and D.S. Allen and has published in prestigious journals such as The Lancet, European Journal of Cancer and Nutrition and Cancer.

In The Last Decade

D.Y. Wang

42 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D.Y. Wang United Kingdom	20	374	311	285	168	137	42	916
F Kuttenn France	12	167 0.4×	421 1.4×	296 1.0×	238 1.4×	69 0.5×	46	914
S. Jacobs United States	23	233 0.6×	452 1.5×	116 0.4×	152 0.9×	140 1.0×	46	1.3k
Julian Peto United Kingdom	13	523 1.4×	231 0.7×	228 0.8×	462 2.8×	169 1.2×	15	1.1k
Sten Gershagen Sweden	14	129 0.3×	131 0.4×	231 0.8×	188 1.1×	31 0.2×	25	689
D. Y. Wang United Kingdom	12	212 0.6×	143 0.5×	109 0.4×	66 0.4×	101 0.7×	20	452
A. Norgren Sweden	14	126 0.3×	148 0.5×	69 0.2×	96 0.6×	126 0.9×	42	680
Ada R. Wolfsen United States	18	117 0.3×	64 0.2×	256 0.9×	235 1.4×	38 0.3×	24	867
Xuan-Ping Pang United States	16	135 0.4×	99 0.3×	467 1.6×	289 1.7×	65 0.5×	23	830
Karen Novik United Kingdom	8	143 0.4×	409 1.3×	95 0.3×	601 3.6×	116 0.8×	8	912
Carles Zafón Spain	18	142 0.4×	139 0.4×	518 1.8×	252 1.5×	77 0.6×	73	968

Countries citing papers authored by D.Y. Wang

Since Specialization

Citations

This map shows the geographic impact of D.Y. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.Y. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.Y. Wang more than expected).

Fields of papers citing papers by D.Y. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.Y. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.Y. Wang. The network helps show where D.Y. Wang may publish in the future.

Co-authorship network of co-authors of D.Y. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of D.Y. Wang. A scholar is included among the top collaborators of D.Y. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.Y. Wang. D.Y. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, D.Y., Walter M. Gregory, Ian S. Fentiman, et al.. (1994). Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer. European Journal of Cancer. 30(4). 445–448. 38 indexed citations

Hamed, H., D.Y. Wang, John W. Moore, G.M.G. Clark, & IS Fentiman. (1990). Growth factor and electrolyte concentration in human breast cyst fluid. European Journal of Cancer and Clinical Oncology. 26(4). 479–480. 5 indexed citations

Wang, D.Y., H. Hamed, C. Ian Mockridge, & Ian S. Fentiman. (1989). Radioimmunoassayable insulin-like growth factor-I in human breast cyst fluid. European Journal of Cancer and Clinical Oncology. 25(5). 867–872. 17 indexed citations

King, R.J.B., D.Y. Wang, Roger J. Daly, & Philippa D. Darbre. (1989). Approaches to studying the role of growth factors in the progression of breast tumours from the steroid sensitive to insensitive state. Journal of Steroid Biochemistry. 34(1-6). 133–138. 34 indexed citations

Key, Timothy J., Malcolm C. Pike, John W. Moore, et al.. (1989). The relationships of SHBG with current and previous use of oral contraceptives and oestrogen replacement therapy. Contraception. 39(2). 179–186. 16 indexed citations

Wang, D.Y., Bianca De Stavola, R.D. Bulbrook, et al.. (1988). The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. European Journal of Cancer and Clinical Oncology. 24(7). 1225–1231. 63 indexed citations

Fentiman, Ian S., et al.. (1988). PERIOPERATIVE BROMOCRIPTINE ADJUVANT TREATMENT FOR OPERABLE BREAST CANCER. The Lancet. 331(8586). 609–610. 17 indexed citations

Waard, F. de & D.Y. Wang. (1988). Epidemiology and prevention: Workshop report. European Journal of Cancer and Clinical Oncology. 24(1). 45–48. 6 indexed citations

Moore, John W., T J Key, G.M.G. Clark, et al.. (1988). Concentrations of Sex-Hormone-Binding-Globulin (SHBG) in a population of normal women: Relationship to risk factors for breast cancer. Steroids. 52(4). 391–392. 6 indexed citations

10.

Fentiman, IS, Maira Caleffi, D.Y. Wang, et al.. (1988). The binding of blood‐borne estrogens in normal vegetarian and omnivorous women and the risk of breast cancer. Nutrition and Cancer. 11(2). 101–106. 14 indexed citations

11.

Wang, D.Y., C. Ian Mockridge, Vera Fantl, et al.. (1988). Urinary epidermal growth factor excretion and breast cancer risk. European Journal of Cancer and Clinical Oncology. 24(6). 1049–1053. 2 indexed citations

12.

Wang, D.Y., Bianca De Stavola, R.D. Bulbrook, et al.. (1987). The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. European Journal of Cancer and Clinical Oncology. 23(10). 1541–1548. 43 indexed citations

13.

Wang, D.Y., S. J. HAMPSON, H. G. Kwa, et al.. (1986). Serum prolactin levels in women with breast cancer and their relationship to survival. European Journal of Cancer and Clinical Oncology. 22(4). 487–492. 43 indexed citations

14.

Hayward, J.L., F. C. Greenwood, Gary A. Glober, et al.. (1978). Endocrine status in normal British, Japanese and Hawaiian-Japanese women. European Journal of Cancer (1965). 14(11). 1221–1228. 34 indexed citations

15.

Wang, D.Y., J.L. Hayward, R.D. Bulbrook, et al.. (1976). Plasma dehydroepiandrosterone and androsterone sulphates, androstenedione and urinary androgen metabolites in normal British and Japanese women. European Journal of Cancer (1965). 12(12). 951–958. 27 indexed citations

16.

Thomas, B.S., et al.. (1976). Plasma dehydroepiandrosterone concentration in normal women and in patients with benign and malignant breast disease. European Journal of Cancer (1965). 12(5). 405–409. 19 indexed citations

17.

Bulbrook, R.D., D.Y. Wang, J.L. Hayward, et al.. (1976). Breast cancer in Britain and Japan: Plasma oestradiol-17β, oestrone and progesterone, and their urinary metabolites in normal British and Japanese women. European Journal of Cancer (1965). 12(9). 725–735. 37 indexed citations

18.

Wang, D.Y., et al.. (1974). Studies on the sulphate esters of dehydroepiandrosterone and androsterone in the blood of women with breast cancer. European Journal of Cancer (1965). 10(8). 477–482. 32 indexed citations

19.

Bulbrook, R.D., et al.. (1973). EFFECT OF STEROIDAL CONTRACEPTIVES ON LEVELS OF PLASMA ANDROGEN SULPHATES AND CORTISOL. The Lancet. 301(7804). 628–631. 49 indexed citations

20.

Wang, D.Y., R.D. Bulbrook, & Peter Clifford. (1966). PLASMA-TESTOSTERONE LEVELS IN KENYAN MEN IN RELATION TO CANCER OF THE NASOPHARYNX. The Lancet. 288(7477). 1342–1344. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact